Gary Schaer to Genetic Therapy
This is a "connection" page, showing publications Gary Schaer has written about Genetic Therapy.
Connection Strength
0.152
-
An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ Res. 2013 Mar 01; 112(5):816-25.
Score: 0.100
-
One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients. Am J Cardiol. 2003 Aug 15; 92(4):436-9.
Score: 0.052